论文部分内容阅读
糖尿病是由于胰岛素分泌受阻等方面的影响,导致体内葡萄糖无法分解,体内血糖值增高,多表现为消瘦、多食等。我国发病率较高,常会引起冠心病等并发症,增加了糖尿病患者的致死率[2]。利拉鲁肽是临床上被广泛运用于治疗2型糖尿病伴冠心病的人胰高糖素样肽-1(GLP-1)类似物,疗效显著。为此,本文特探讨不同剂量利拉鲁肽治疗2型糖尿
Diabetes is due to blocked insulin secretion and other aspects of the impact, leading to in vivo glucose can not be broken down, the body increased blood sugar levels, more performance for weight loss, more food and so on. The higher incidence of our country, often lead to complications such as coronary heart disease, increased the mortality of diabetic patients [2]. Liraglutide is clinically widely used in the treatment of type 2 diabetes with coronary glucagon-like peptide-1 (GLP-1) analogues, with significant effect. To this end, this article special discussion of different doses of liraglutide treatment of type 2 diabetes